Defensive medicine and medical liability concerns create a symbiotic relationship that costs everyone in the medical system. Has healthcare reform legislation addressed the medical malpractice issue, and will it do enough to contain healthcare costs? Dr. Mark McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution, former commissioner of the FDA and administrator of the Centers for Medicare and Medicaid Services, discusses the impact of defensive medicine on the healthcare system. Dr. McClellan also suggests that health information technology will play a significant role in bending the healthcare cost curve by ensuring safety, as well as increasing coordination of care and effective communication. Among states have taken up tort reform, how successful have these reforms been at reducing liability pressure and overall healthcare costs? Hosted by Dr. Jack Lewin.
Healthcare Cost Containment and Medical Liability Reform

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Defensive medicine and medical liability concerns create a symbiotic relationship that costs everyone in the medical system. Has healthcare reform legislation addressed the medical malpractice issue, and will it do enough to contain healthcare costs? Dr. Mark McClellan, director of the Engelberg Center for Health Care Reform at the Brookings Institution, former commissioner of the FDA and administrator of the Centers for Medicare and Medicaid Services, discusses the impact of defensive medicine on the healthcare system. Dr. McClellan also suggests that health information technology will play a significant role in bending the healthcare cost curve by ensuring safety, as well as increasing coordination of care and effective communication. Among states have taken up tort reform, how successful have these reforms been at reducing liability pressure and overall healthcare costs? Hosted by Dr. Jack Lewin.
Produced in Cooperation with
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
A Practical Guide to Prescribing in HF
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?